VR Adviser as of Dec. 31, 2022
Portfolio Holdings for VR Adviser
VR Adviser holds 29 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Miragen Therapeutics (VRDN) | 12.7 | $79M | 2.7M | 29.21 | |
| Aclaris Therapeutics (ACRS) | 11.5 | $72M | 4.6M | 15.75 | |
| Axsome Therapeutics (AXSM) | 8.3 | $52M | 671k | 77.13 | |
| Cogent Biosciences (COGT) | 7.5 | $47M | 4.0M | 11.56 | |
| Terns Pharmaceuticals (TERN) | 6.1 | $38M | 3.7M | 10.18 | |
| Gh Research Ordinary Shares (GHRS) | 5.5 | $34M | 3.5M | 9.72 | |
| Celcuity (CELC) | 4.7 | $30M | 2.1M | 14.01 | |
| Dbv Technologies S A Sponsored Adr (DBVT) | 4.7 | $29M | 9.3M | 3.15 | |
| Dice Therapeutics | 4.1 | $26M | 819k | 31.20 | |
| Aerovate Therapeutics (AVTE) | 3.5 | $22M | 748k | 29.30 | |
| Pliant Therapeutics (PLRX) | 3.4 | $21M | 1.1M | 19.33 | |
| Kalvista Pharmaceuticals (KALV) | 3.2 | $20M | 2.9M | 6.76 | |
| Novavax Com New (NVAX) | 3.1 | $19M | 1.9M | 10.28 | |
| Merus N V (MRUS) | 3.0 | $19M | 1.2M | 15.47 | |
| Cabaletta Bio (CABA) | 2.8 | $18M | 1.9M | 9.25 | |
| Annexon (ANNX) | 2.7 | $17M | 3.2M | 5.17 | |
| Vectivbio Hldg Ord Shs | 2.6 | $16M | 1.9M | 8.66 | |
| Provention Bio | 1.9 | $12M | 1.1M | 10.57 | |
| Savara (SVRA) | 1.6 | $9.8M | 6.4M | 1.55 | |
| Milestone Pharmaceuticals (MIST) | 1.4 | $8.7M | 2.2M | 3.96 | |
| Lianbio Sponsored Ads (LIANY) | 1.3 | $7.9M | 4.8M | 1.64 | |
| Marinus Pharmaceuticals Com New (MRNS) | 1.1 | $7.0M | 1.8M | 3.98 | |
| Trevi Therapeutics (TRVI) | 0.9 | $5.9M | 3.1M | 1.93 | |
| Fulcrum Therapeutics (FULC) | 0.5 | $3.3M | 447k | 7.28 | |
| Lyra Therapeutics (LYRA) | 0.5 | $2.9M | 924k | 3.14 | |
| Inozyme Pharma (INZY) | 0.5 | $2.8M | 2.7M | 1.05 | |
| Atyr Pharma Com New (LIFE) | 0.4 | $2.6M | 1.2M | 2.19 | |
| Affimed Therapeutics B V | 0.3 | $1.8M | 1.4M | 1.24 | |
| Rallybio Corp (RLYB) | 0.3 | $1.8M | 269k | 6.57 |
